Predominately, in the Indian tradition, the species Piper longum could play a significant role in the management of several severe disorders such as asthma, tuberculosis, rheumatism, and epilepsy. Mostly, the plant root would be responsible for treating insomnia, rheumatism, and epilepsy, as well as plant leaves for a prevailing stimulant for both the digestive and the respiratory systems. The alcoholic extract of P. longum fruits showed antiamoebic, anti-inflammatory, and immunomodulatory potential in experimental animals. In addition to these benefits, the current study concluded that the examination of the ethanolic extract of P. longum fruits as an anti-hyperglycemic in streptozotocin (STZ)-induced diabetic animal model (Wistar rats). A diabetic condition could be induced in an animal model by dissolving STZ in a 0.1 M citrate buffer of pH 4.5. It was injected intraperitoneally at a dose of 50 mg/kg body weight in the animal test model. All the test animals were fed with a 5% dextrose solution to control overnight hypoglycemic conditions. Subsequently, 48 hours of hyperglycemic test animals were selected for the study. The observed anti-hyperglycemic effect of ethanolic extract of P. longum dried fruits should correspond to that of the reference standard, i.e., glibenclamide. The study reveals that the ethanolic extract of P. longum fruits has a promising potential as an anti-hyperglycemic in the STZ-induced diabetic animal test model. So, it is presumed that the ethanolic extract of P. longum could be a promising alternative for severe diabetes complications such as hyperglycemia, oxidative stress, etc., in the near future